Anemia during Pegylated Interferon-Ribavirin Therapy Results from Both Increase Suppression of Erythroid Differentiation and Hemolysis
Luisa Ronzoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessandra Colancecco(University of Milan), Alessio Aghemo, Maria Grazia Rumi(University of Milan), Sara Monico(University of Milan), Massimo Colombo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Paolo Grillo(University of Pavia)
Cited by 1
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Thalassaemia
|The Lancet|2017|763
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631